DEXE extends rally as buyers keep control but momentum slows
DeXe (DEXE) is trading at $1.95, rising 7.04% today in a session marked by high volatility. The asset currently trades above its short- and medium-term moving averages, while it remains well below longer-term trend levels.
Highlights
- DEXE/USD trades above short- and medium-term moving averages, indicating persistent short-term bullish momentum despite long-term weakness.
- Momentum signals are mixed, with strong buy indications from MACD and buyer control, but oversold oscillators warn of a possible short-term pause.
- Price is at $1.95, up 7.04% today, with an expected 2 to 3 day range of $1.78 to $2.03 and no clear directional bias.
Mixed signals and resistance gap shape upside momentum risk
On the H1 chart, DEXE/USD has crossed above both the MA-20 ($1.92) and MA-50 ($1.91), with the long-term MA-200 up at $11.52 signaling a substantial distance from major resistance. Immediate support is established by the Ichimoku Kijun at $1.91. Momentum indicators show mixed readings: while MACD gives a strong buy signal and ADX highlights prevailing buyer control, RSI is neutral at 53.19, Stochastic RSI points to oversold conditions, CCI signals neutrality, Bull/Bear Power shows buyers dominating intraday, and the Awesome Oscillator remains neutral. Oscillator divergences suggest upside momentum could soon pause or see a brief retracement.
Consolidation base forms as breakout hinges on key support
Over the next 2–3 trading days, DEXE/USD is likely to trade within a typical volatility band from $1.78 to $2.03. The probability of a move higher or lower is evenly balanced at 50% each. Consolidation near current levels is the baseline expectation, with a bullish breakout targeting a sustained move above $2.03 and a bearish scenario emerging if support at $1.91 breaks, potentially sending the price down to the $1.78 region.
Earlier, analysts noted that DeXe was experiencing persistent bearish momentum, with downside risks dominating the outlook. The latest price action introduces a potentially pivotal shift, making $1.91 a critical support level to monitor for confirmation of sustained recovery or renewed weakness in the sessions ahead.